McKesson Q1 EPS $5.15; Sells 13% Medical-Surgical Stake for $1.25B
McKesson Corporation reported mixed financial results for the three months ended June 30, 2026, with revenues increasing to $105,380 million, but net income attributable to McKesson Corporation decreasing 21.7% to $614 million, and diluted EPS falling 17.6% to $5.15. The company completed the sale of a 13% minority ownership interest in its Medical-Surgical Solutions business for approximately $1.25 billion and incurred higher restructuring charges of $136 million. Net cash used in operating activities improved significantly to $(220) million.
Key Highlights
- Net income attributable to McKesson Corporation decreased 21.7% to $614 million.
- Diluted earnings per common share decreased 17.6% to $5.15.
- Revenues increased 7.7% to $105,380 million for the quarter.
- Sold a 13% minority interest in Medical-Surgical Solutions for $1.25 billion.
- Restructuring, impairment, and related charges increased to $136 million.
- Net cash used in operating activities improved to $(220) million.
- Issued $3.215 billion in long-term debt, including new Medical-Surgical facilities.
Price Impact
More from MCK
McKesson Q1 Adj. EPS $9.93 (+20%); Raises FY27 Guidance to $44.20-$45.00
McKesson Announces Executive Vice President Retirement, New Appointment
McKesson Announces 2026 Annual Meeting Details and Board Leadership Changes